Latest filing published 21 Mar 2017 for Kiora Pharmaceuticals INC, €12k.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -53.8%Entry US$32,400.00 · Close at T+365 US$14,963.40
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Ventech Capital II: trading record in brief
This profile gathers the share dealings of Ventech Capital II across 2 companies, led by Kiora Pharmaceuticals Inc and Scynexis Inc. Between 7 May 2014 and 13 March 2017, the trades on record add up to 19 filings.
The open-market side counts 2 purchases for €742k alongside 6 sales for €172k. Taken together, the purchases exceed the sales by €570k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 3 share grants. 2017 to date brings no purchases and 1 sale.
The newest entry dates from 21 March 2017: an open-market sale of €12k, in Kiora Pharmaceuticals Inc. The clock since the last published purchase (23 February 2015) now reads 4,277 days. The median gap between a trade and its publication by SEC (Form 4) is 1 day. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Ventech Capital II
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 4,419 shares@ US$2.806.7% of flowCommon StockSEC:0001144204-17-015872:0
- 13,167 shares@ US$3.0820.8% of flowCommon StockSEC:0001144204-16-107882:0
- 15,433 shares@ US$3.0023.7% of flowCommon StockSEC:0001144204-16-107882:1
- 10,000 shares@ US$3.2716.7% of flowCommon StockSEC:0001144204-16-107705:0
- 17,000 shares@ US$3.2428.1% of flowCommon StockSEC:0001144204-16-107705:1
- 2,400 shares@ US$3.203.9% of flowCommon StockSEC:0001144204-16-107705:2
- 506,563 sharesCommon StockSEC:0001144204-15-011504:0
- 142,218 sharesCommon StockSEC:0001144204-15-011504:1
- 501,405 sharesCommon StockSEC:0001144204-15-011504:2
- 241,270 shares@ US$4.20Common StockSEC:0001144204-15-011504:3
- 102,777 shares@ US$6.00Common StockSEC:0001144204-15-011504:4Canonical exit: 20 May 2015 (T+90)
- 96,294 sharesCommon StockSEC:0001209191-14-032426:4
- 39,685 sharesCommon StockSEC:0001209191-14-032426:5
- 30,930 sharesCommon StockSEC:0001209191-14-032426:3
- 147,588 sharesCommon StockSEC:0001209191-14-032426:6
- 14,005 shares@ US$0.20Common StockSEC:0001209191-14-032426:0
- 43,704 shares@ US$0.20Common StockSEC:0001209191-14-032426:2
- 28,000 shares@ US$10.00Common StockSEC:0001209191-14-032426:7Canonical exit: 5 Aug 2014 (T+90)
18 of 18 declarations